Ireland Suspends AstraZeneca Vaccine Amid Blood Clot Reports

2
FILE - In this Wednesday, March 10, 2021 file photo, a health worker administers a dose of the AstraZeneca vaccine against COVID-19 to a patient inside the convention center known as "La Nuvola", The Cloud, in Rome. Irish health officials have recommended the temporary suspension of the AstraZeneca vaccine after reports of serious blood clotting after inoculations in Norway. Dr. Ronan Glynn, Ireland’s deputy chief medical officer, said Sunday, March 14 the recommendation was made after Norway’s medicines agency reported four cases of blood clotting in adults after receiving the AstraZeneca vaccine. (AP Photo/Andrew Medichini, file)

LONDON (AP) — Irish health officials on Sunday recommended the temporary suspension of the AstraZeneca vaccine after reports of serious blood clotting after inoculations in Norway.

Join our WhatsApp group

Subscribe to our Daily Roundup Email


Dr. Ronan Glynn, Ireland’s deputy chief medical officer, said the recommendation was made after Norway’s medicines agency reported four cases of blood clotting in adults after receiving the AstraZeneca vaccine.

He said that while there was no conclusive link between the vaccine and the cases, Irish health officials are recommending the suspension of the vaccine’s rollout as a precaution. Danish, Norwegian and Icelandic authorities have taken similar precautionary steps.

AstraZeneca said in a statement Sunday that it “would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence.”

“The safety of the public will always come first,” the British-Swedish biopharmaceutical company said, adding that it’s “keeping this issue under close review but available evidence does not confirm that the vaccine is the cause.”

The company said that a review of safety data of more than 17 million people who have received the AstraZeneca vaccine in the European Union and the U.K. “has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country.”

The World Health Organization and the European Union’s medicines regulator have previously said that there was no link between the jab and an increased risk of developing a clot.


Listen to the VINnews podcast on:

iTunes | Spotify | Google Podcasts | Stitcher | Podbean | Amazon

Follow VINnews for Breaking News Updates


Connect with VINnews

Join our WhatsApp group


2 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
Dusk
Dusk
3 years ago

Why are you not publishing articles about Ivermectin? It is an anti-parasitic medicine, has highly potent anti-viral and anti-inflammatory properties against COVID-19. It is used for both prophylaxis and treatment of COVID-19. It is also very effective for Persistent or Post-Acute Symptoms of COVID- 19. People are suffering in severe pain and having to be admitted to hospital!! This drug takes the pain away and stops COVID from replicating itself within ONE HOUR of administration!! Why are doctors refusing to prescribe it? Why is press not publishing articles about it? WHY?

Just Sayin
Just Sayin
3 years ago

Another proof showing the continuous rigorous safety tests to ensure the safety of our vaccines. If there is even a slight suspicion that it might produce any harm, the vaccine is suspended.